BGS Beta-Gamma-Service expands laboratory and logistics spaces

Lab extension starts up at headquarters in Wiehl, spaces for logistics and production will also be created

Wiehl, 8 June 2022 – BGS, specialised provider in the area of radiation sterilization and radiation crosslinking, is expanding its halls for logistics and production in Wiehl (NRW). In order to meet the increased material testing requirements for radiation crosslinking, the company is also investing in the extension of a new laboratory. With the announced extended storage capacities, BGS is responding in particular to the increased need for sterilization services in the sectors of biotechnology, medicine and diagnostics. Overall, BGS is investing a seven-digit amount in the expansion. The additionally planned spaces amount to 1,000 sq m.

“The demand for sterilization capacities is rising steadily. Continuously more orders for crosslinking are being placed at our headquarters in Wiehl. After the move to our new administration quarters in 2020, it is an ideal time to consolidate the freed up space, improve the internal flow of goods in the process, and use the new capacities optimally for the further growth of our company,” explains managing director Dr. Andreas Ostrowicki. “The material testing requirements are also increasing commensurate with the rising number of orders for crosslinking services. With our new spatial possibilities and cutting-edge test equipment, BGS is well prepared to meet the increased requirements.” Depending on the product and the respective area of application, BGS carries out the relevant test procedures such as measuring the degree of crosslinking as well as rheological measurements, amongst others, for customers from the automotive industry, machine construction and the cable and pipe industry. The completion of all construction measures is planned for 2024.

New laboratory supports R & D activities of the medium-sized company

The new equipment and possibilities in the laboratory also benefit the research and development department at BGS. “The focus of our R & D activities at present is the development of new, crosslinkable materials, alternative crosslinking aids and solutions for the sustainability of radiation-crosslinked parts and components,” declares managing director Ostrowicki. “As part of the German innovation network ZIM (Central Innovation Programme) MED-IG-4.0, we are additionally working to further accelerate the progress of the Internet of Things in the medical sector: For example, together with 22 other medium-sized enterprises, we analyse the need for intelligent products and systems from thermoplastic materials, develop new products and improve existing solutions.”

This year, for the first time, Stifterverband für die Deutsche Wissenschaft e.V. (Donors’ Association for the Promotion of Sciences and Humanities in Germany) awarded BGS the seal “Innovative through Research” for its achievements in the area of research and development.